Published in J Virol on September 01, 1993
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
Comparative genomics of foot-and-mouth disease virus. J Virol (2005) 3.42
Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol (1995) 2.66
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol (1997) 2.51
RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc Natl Acad Sci U S A (1994) 2.49
Differential utilization of poly(rC) binding protein 2 in translation directed by picornavirus IRES elements. RNA (1999) 2.00
Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J Virol (2002) 1.88
Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol (1998) 1.83
Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their mengovirus counterparts. J Virol (1995) 1.62
The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J Virol (1995) 1.61
Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J Virol (1998) 1.52
Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol (2000) 1.44
Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol (1999) 1.43
Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J Virol (1995) 1.42
Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol (1996) 1.35
Mutational analysis of the mengovirus poly(C) tract and surrounding heteropolymeric sequences. J Virol (1996) 1.34
The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol (2006) 1.30
Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J Virol (2001) 1.28
Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus. J Virol (2003) 1.27
Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J Virol (1995) 1.23
Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture. J Virol (1994) 1.21
Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol (2007) 1.20
Analysis of foot-and-mouth disease virus internalization events in cultured cells. J Virol (2005) 1.17
Emergence in Asia of foot-and-mouth disease viruses with altered host range: characterization of alterations in the 3A protein. J Virol (2001) 1.12
Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses. J Virol (2003) 1.11
Identification of RNA helicase A as a new host factor in the replication cycle of foot-and-mouth disease virus. J Virol (2009) 1.10
Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J Virol (2005) 1.04
Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins. J Virol (2004) 1.03
Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J Virol (1994) 1.02
Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity. J Virol (1997) 1.01
Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine. J Virol (1997) 1.00
A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. J Virol (2012) 0.99
Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1996) 0.99
High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit. J Virol (2000) 0.98
A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function. J Virol (2008) 0.97
Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers. J Virol (2007) 0.97
Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design. Nat Struct Mol Biol (2015) 0.97
Terminal RNA replication elements in human parechovirus 1. J Virol (2002) 0.95
Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol (2005) 0.95
Expression and stability of foreign epitopes introduced into 3A nonstructural protein of foot-and-mouth disease virus. PLoS One (2012) 0.88
Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics. BMC Vet Res (2012) 0.87
Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA. J Virol (2003) 0.87
Tandem mengovirus 5' pseudoknots are linked to viral RNA synthesis, not poly(C)-mediated virulence. J Virol (1996) 0.86
Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease. J Virol (2011) 0.84
The poly(C) region affects progression of encephalomyocarditis virus infection in Langerhans' islets but not in the myocardium. J Virol (1997) 0.82
In-vitro and in-vivo phenotype of type Asia 1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites. BMC Microbiol (2011) 0.81
Analysis of SAT type foot-and-mouth disease virus capsid proteins and the identification of putative amino acid residues affecting virus stability. PLoS One (2013) 0.81
Capsid coding sequences of foot-and-mouth disease viruses are determinants of pathogenicity in pigs. Vet Res (2012) 0.80
Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development. PLoS One (2013) 0.79
Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response. J Virol (2015) 0.78
Examination of soluble integrin resistant mutants of foot-and-mouth disease virus. Virol J (2013) 0.78
Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine. Vet Res (2014) 0.78
A Universal Next-Generation Sequencing Protocol To Generate Noninfectious Barcoded cDNA Libraries from High-Containment RNA Viruses. mSystems (2016) 0.78
Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication. J Virol (2014) 0.78
Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses. J Virol (2014) 0.77
Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa. Arch Virol (2013) 0.77
Theiler's murine encephalomyelitis virus contrasts with encephalomyocarditis and foot-and-mouth disease viruses in its functional utilization of the StopGo non-standard translation mechanism. J Gen Virol (2012) 0.77
Repeated exposure to 5D9, an inhibitor of 3D polymerase, effectively limits the replication of foot-and-mouth disease virus in host cells. Antiviral Res (2013) 0.75
SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability. J Virol (2017) 0.75
Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection. Virol J (2017) 0.75
Inhibition of EHMT2 Induces a Robust Antiviral Response Against Foot-and-Mouth Disease and Vesicular Stomatitis Virus Infections in Bovine Cells. J Interferon Cytokine Res (2015) 0.75
Isolation, identification and complete genome sequence analysis of a strain of foot-and-mouth disease virus serotype Asia1 from pigs in southwest of China. Virol J (2011) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res (1987) 25.34
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res (1989) 10.50
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 8.59
The mechanism of RNA recombination in poliovirus. Cell (1986) 5.35
Production of single-stranded DNA templates by exonuclease digestion following the polymerase chain reaction. Nucleic Acids Res (1989) 4.70
Low copy number plasmids for regulated low-level expression of cloned genes in Escherichia coli with blue/white insert screening capability. Nucleic Acids Res (1990) 3.79
Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol (1985) 2.65
Cloning and synthesis of infectious cardiovirus RNAs containing short, discrete poly(C) tracts. J Virol (1989) 2.56
Chimeric cDNA clones: a novel PCR artifact. Nucleic Acids Res (1991) 2.07
Attenuation of Mengo virus through genetic engineering of the 5' noncoding poly(C) tract. Nature (1990) 2.05
Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J Virol (1987) 2.02
Poly(C) in animal viral RNAs. Nature (1974) 1.95
Sequence and location of the poly C tract in aphtho- and cardiovirus RNA. Nucleic Acids Res (1979) 1.95
Presence of a large poly(rC) tract within the RNA of encephalomyocarditis virus. Nature (1974) 1.83
Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77
Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1989) 1.71
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA. J Virol (1978) 1.69
Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus. Nucleic Acids Res (1987) 1.62
Poly(C) sequence is located near the 5'-end of encephalomyocarditis virus RNA. Biochem Biophys Res Commun (1976) 1.58
Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. J Virol (1990) 1.54
The location of the ploy(C) tract in the RNA of foot-and-mouth disease virus. J Gen Virol (1976) 1.52
Biochemical analysis of a virulent and an avirulent strain of foot-and-mouth disease virus. J Gen Virol (1977) 1.52
Modifications of the 5' untranslated region of foot-and-mouth disease virus after prolonged persistence in cell culture. Virus Res (1992) 1.40
The sequence of foot-and-mouth disease virus RNA to the 5' side of the poly(C) tract. Gene (1985) 1.31
Foot-and-mouth disease virion RNA: studies on the relation between the length of its 3'-poly(A) segment and infectivity. Virology (1979) 1.25
Gross rearrangements within the 5'-untranslated region of the picornaviral genomes. Nucleic Acids Res (1990) 1.13
The genomic RNA of mengovirus. I. Location of the poly(C) tract. Virology (1977) 1.00
Comparison of the nucleotide sequence at the 5' end of RNAs from nine aphthoviruses, including representatives of the Seven serotypes. J Virol (1980) 0.97
Heterogeneity of the polyribocytidilic acid tract in aphthovirus: changes in the size of the poly(C) of viruses recovered from persistently infected cattle. Virology (1988) 0.91
Creating chimeric molecules by PCR directed homologous DNA recombination. Nucleic Acids Res (1991) 0.90
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature (1989) 5.87
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50
Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature (1987) 5.26
The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol (1989) 3.53
The proteins of biologically active sub-units of vesicular stomatitis virus. J Gen Virol (1970) 3.44
Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) Am J Med Genet (1996) 3.17
Dissection of vesicular stomatitis virus into the infective ribonucleoprotein and immunizing components. J Gen Virol (1970) 2.85
Serological relationships between different strains of vesicular stomatis virus. J Gen Virol (1972) 2.68
Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol (1995) 2.66
Kinetic tuning of myosin via a flexible loop adjacent to the nucleotide binding pocket. J Biol Chem (1998) 2.62
Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology (1984) 2.60
The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus. J Gen Virol (1967) 2.57
Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature (1984) 2.52
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol (1997) 2.51
3'-Terminal nucleotide sequences in the genome RNA of picornaviruses. Nature (1978) 2.40
Protein covalently linked to foot-and-mouth disease virus RNA. Nature (1977) 2.35
Location of the initiation site for protein synthesis on foot-and-mouth disease virus RNA by in vitro translation of defined fragments of the RNA. J Virol (1980) 2.34
Characterisation of a rotavirus.20b. Nature (1975) 2.21
Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology (1992) 2.15
A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol (1973) 2.08
A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06
The importance of inorganic phosphate in regulation of energy metabolism of Streptococcus lactis. J Biol Chem (1981) 2.05
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature (1987) 2.00
Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol (1993) 1.97
Sequence and location of the poly C tract in aphtho- and cardiovirus RNA. Nucleic Acids Res (1979) 1.95
Poly(C) in animal viral RNAs. Nature (1974) 1.95
Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol (1999) 1.94
Model for vesicular stomatitis virus. J Virol (1972) 1.92
The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components. J Immunol (1966) 1.89
Infective virus substructure from vesicular stomatitis virus. J Virol (1967) 1.89
Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature (1990) 1.86
Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol (1998) 1.83
Surface structure of vesicular stomatitis virus. J Gen Virol (1969) 1.82
Further physicochemical characterization of Nodamura virus. Evidence that the divided genome occurs in a single component. J Gen Virol (1978) 1.78
Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology (1992) 1.76
A foot and mouth disease syndrome in pigs caused by an enterovirus. Nature (1968) 1.74
Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes. Nature (1981) 1.73
Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology (1993) 1.72
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA. J Virol (1978) 1.69
Presence of a covalently linked protein on calicivirus RNA. J Gen Virol (1978) 1.66
Antigenic differences between isolates of swine vesicular disease virus and their relationship to Coxsackie B5 virus. Nature (1973) 1.63
The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J Virol (1995) 1.61
Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine (1999) 1.61
Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature (1987) 1.57
Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology (1991) 1.55
Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med (1997) 1.54
The location of the ploy(C) tract in the RNA of foot-and-mouth disease virus. J Gen Virol (1976) 1.52
Biochemical analysis of a virulent and an avirulent strain of foot-and-mouth disease virus. J Gen Virol (1977) 1.52
Heterogeneity of the genome-linked protein of foot-and-mouth disease virus. J Virol (1980) 1.50
Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus. J Gen Virol (1979) 1.50
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration (1995) 1.45
Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol (2000) 1.44
Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine (1994) 1.43
Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J Virol (1995) 1.42
Formaldehyde as an inactivant. Vaccine (1995) 1.42
Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor. J Med Chem (1991) 1.42
Mental health concerns of Canadian adolescents: a consumer's perspective. Can J Psychiatry (1996) 1.41
"Instant-mix" whole brain photon with neutron boost radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys (1990) 1.40
Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir. Clin Pharmacol Ther (1998) 1.40
Sleep habits and patterns of college students: a preliminary study. J Am Coll Health (2001) 1.40
Partial nucleotide sequence of the Japanese encephalitis virus genome. Virology (1987) 1.39
Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK. Nature (1981) 1.39
The antigens of vesicular stomatitis virus. II. The presence of two low molecular weight immunogens in virus suspensions. J Immunol (1966) 1.38
Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br J Pharmacol (1999) 1.38
Picornaviridae. Intervirology (1974) 1.36
Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol (1996) 1.35
Effects of posterior fossa decompression with and without duraplasty on Chiari malformation-associated hydromyelia. Neurosurgery (2000) 1.35
Autogenous vein grafting in femoropopliteal atherosclerosis: the limits of its effectiveness. Surgery (1979) 1.34
Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J Virol (2001) 1.33
Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol (1984) 1.30
Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection. Virology (1995) 1.29
Buoyant density of picornaviruses in caesium salts. J Gen Virol (1971) 1.28
A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus. J Gen Virol (1975) 1.27
Host cell selection of antigenic variants of foot-and-mouth disease virus. J Gen Virol (1989) 1.26
Surface structure of foot-and-mouth disease virus. J Gen Virol (1969) 1.25
Differential precipitation of foot and mouth disease virus proteins made in vivo and in vitro by hyperimmune and virus particle guinea pig antisera. Virology (1981) 1.24
A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology (1992) 1.24
Current embryology and treatment of gastroschisis and omphalocele. Arch Surg (1966) 1.24
Tryptic peptide analysis of the structural proteins of vesicular stomatitis virus. J Gen Virol (1978) 1.24
Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J Virol (1998) 1.23
Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J Virol (1995) 1.23
A model for vesicular exanthema virus, the prototype of the calicivirus group. J Gen Virol (1978) 1.22
Further evidence for multiple proteins in the foot-and-mouth disease virus particle. J Gen Virol (1971) 1.22
Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses. J Gen Virol (1979) 1.22
Sindbis vectors suppress secretion of subviral particles of Japanese encephalitis virus from mammalian cells infected with SIN-JEV recombinants. Virology (1995) 1.21
Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol (1996) 1.21
Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture. J Virol (1994) 1.21
Biochemical mapping of the foot-and-mouth disease virus genome. J Gen Virol (1977) 1.21
A model for foot-and-mouth disease virus. J Gen Virol (1972) 1.19
Childhood bereavement and subsequent psychiatric disorder. Br J Psychiatry (1966) 1.19
Encephalomyocarditis virus antibodies in sera from apparently normal pigs. Vet Rec (1977) 1.19
Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A. Virology (2001) 1.19
Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol (1999) 1.19
The antigens of vesicular stomatitis virus. 3. Structure and immunogenicity of antigens derived from the virion by treatment with Tween and ether. J Immunol (1967) 1.19
Foot-and-mouth disease virus particles contain replicase protein 3D. Proc Natl Acad Sci U S A (1994) 1.18
Absence of poly (A) from the infective RNA of Nodamura virus. J Gen Virol (1976) 1.18